Propranolol therapy for cutaneous infantile haemangiomas initiated safely as a day-case procedure

European Journal of Pediatrics

Volumn 173, Issue 1, 2014, Pages 63-68

  McSwiney, Edward ^a   Murray, Deirdre ^a,b   Murphy, Michelle ^a,c  

^a Department of Medicine National University of Ireland Cork   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c SOUTH INFIRMARY VICTORIA UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Haemangioma; Infant; Pharmacology; Propranolol

Indexed keywords

PROPRANOLOL;

ABSENCE OF SIDE EFFECTS; ARTICLE; CAPILLARY BLOOD; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CUTANEOUS INFANTILE HAEMANGIOMA; DAY CARE; DRUG SAFETY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEMANGIOMA; HUMAN; INFANT; INFANT DISEASE; MALE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCREENING TEST;

ADRENERGIC BETA-ANTAGONISTS; DAY CARE; FEMALE; HEMANGIOMA; HUMANS; INFANT; MALE; PROPRANOLOL; PROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84893682551     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-013-2105-5     Document Type: Article

References (28)

1. Belson MG, Sullivan K, Geller RJ (2001) Beta-adrenergic antagonist exposures in children. Vet Hum Toxicol 43:361-365
2. Bowers RE, Graham EA, Tomlinson KM (1960) The natural history of the strawberry nevus. Arch Dermatol 82:667-680. doi: 10.1001/archderm.1960. 01580050009002
3. Breur JM, de Graaf M, Breugeum CC et al (2011) Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report. Pediatr Dermatol 28:169-171. doi: 10.1111/j.1525-1470.2010.01224.x
4. Chang LC, Haggstrom AN, Drolet BA et al (2008) Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 122:360-367. doi: 10.1542/peds.2007-2767
5. Drolet BA, Swanson EA, Frieden IJ et al (2008) Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr 153:712-715. doi: 10.1016/j.jpeds.2008.05.043
6. Esterly NB (1995) Cutaneous hemangiomas, vascular stains and malformations, and associated syndromes. Curr Probl Dermatol 7(3):65-108. doi: 10.1016/S1040-0486(09)80020-3
7. European Medicines Agency (1995) ICH Topic E 2 A. Clinical safety data management: definitions and standards for expedited reporting. http://www.emea.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/ 09/WC500002749.pdf
8. Gottschling S, Schneider G, Meyer S et al (2006) Two infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide. Pediatr Blood Cancer 46:239-242. doi: 10.1002/pbc.20522
9. Haider KM, Plager DA, Neely DE et al (2010) Outpatient treatment of periocular infantile hemangiomas with oral propranolol. J AAPOS 14:251-256. doi: 10.1016/j.jaapos.2010.05.002
10. Hogeling M, Adams S, Wargon O (2011) A randomized controlled trial of propranolol for infantile haemangiomas. Pediatrics 128:259-266. doi: 10.1542/peds.2010-0029
11. Holland KE, Frieden IJ et al (2010) Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol 146(7):775-778. doi: 10.1001/archdermatol.2010.158
12. Jacobs AH (1957) Strawberry hemangiomas: the natural history of the untreated lesion. Calif Med 86(1):8-10. doi: 10.1097/00006534-195705000-00023
13. Kallen RJ, Mohler JH, Lin HL (1980) Hypoglycemia: a complication of treatment of hypertension with propranolol. Clin Pediatr 19:567-568. doi: 10.1177/000992288001900814
14. Lawley LP, Siegfried E, Todd JL (2009) Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 26:610-614. doi: 10.1111/j.1525-1470.2009.00975.x
15. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T et al (2008) Propranolol for severe hemangiomas of infancy. N Engl J Med 358:2649-2651. doi: 10.1056/NEJMc0708819
16. Litovitz TL, Schmitz BF, Matyunas N (1987) Annual report of the American Association of Poison Control Centers National Data Collection System
17. Love JN, Howell JM, Klein-Schwartz W et al (2006) Lack of toxicity from pediatric beta-blocker exposures. Hum Exp Toxicol 25:341-346. doi: 10.1191/0960327106ht632oa
18. Love JN, Sikka N (2004) Are 1-2 tablets dangerous? Beta-blocker exposure in toddlers. J Emerg Med 26:309-314. doi: 10.1016/j.jemermed.2004.02.010
19. Manunza F, Syed S, Laguda B et al (2010) Propranolol for complicated infantile haemangiomas: a case series of 30 infants (letter). Br J Dermatol 162:466-468. doi: 10.1111/j.1365-2133.2009.09597.x
20. Moroz B (1982) Long-term follow-up of hemangiomas in children. In: Williams HB (ed) Symposium on vascular malformations and melanotic lesions. Mosby, St. Louis, pp 27-35
21. Mulliken JB (1988) Diagnosis and natural history of hemangiomas. In: Mulliken JB, Young AE (eds) Vascular birthmarks: hemangiomas and malformations. Saunders, Philadelphia, pp 41-62
22. Park MK (2008) Pediatric cardiology for practitioners, 5th edn. Mosby, Philadelphia
23. Pavlakovic H, Kietz S, Lauerer P et al (2011) Hyperkalemia complicating propranolol treatment of an infantile hemangioma. Pediatrics 126:1589-1593
24. Sans V, de la Roque BJ et al (2009) Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 124:423-431. doi: 10.1542/peds.2008- 3458
25. Schiestl C, Neuhaus K, Zoller S et al (2011) Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas. Eur J Pediatr 170:493-501. doi: 10.1007/s00431-010-1324-2
26. Schupp CJ, Kleber JB, Günther P et al (2011) Propranolol therapy in 55 infants with infantile hemangioma: dosage, duration, adverse effects, and outcome. Pediatr Dermatol 28(6):640-644. doi: 10.1111/j.1525-1470.2011.01569.x
27. Siegfried EC, Keenan WJ, Al-Jureidini S et al (2008) More on propranolol for hemangiomas of infancy. N Engl J Med 359:2846-2847
28. Truong MT, Perkins JA, Messner AH et al (2010) Propranolol for the treatment of airway hemangiomas: a case series and treatment algorithm. Int J Pediatr Otorhinolaryngol 74(9):1043-1048. doi: 10.1016/j.ijporl.2010.06.001